Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
40
ALL Quote, Financials, Valuation and Earnings
Last price:
$192.25
Seasonality move
:
2.64%
Day range:
$191.80 - $195.73
52-week range:
$176.00 - $215.89
Dividend yield:
2.08%
P/E ratio:
6.23x
P/S ratio:
0.77x
P/B ratio:
1.97x
Volume:
2.4M
Avg. volume:
1.8M
1-year change:
0.62%
Market cap:
$50.3B
Revenue:
$64.1B
EPS (TTM):
$30.89
Analysts' Opinion
-
Consensus RatingThe Allstate Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $236.29, The Allstate Corp. has an estimated upside of 22.89% from its current price of $192.28.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $157.00 representing 18.35% downside risk from its current price of $192.28.
Fair Value
-
According to the consensus of 19 analysts, The Allstate Corp. has 22.89% upside to fair value with a price target of $236.29 per share.
ALL vs. S&P 500
-
Over the past 5 trading days, The Allstate Corp. has underperformed the S&P 500 by -9.05% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Allstate Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Allstate Corp. has grown year-over-year revenues for 13 quarters straight. In the most recent quarter The Allstate Corp. reported revenues of $17.3B.
Earnings Growth
-
The Allstate Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter The Allstate Corp. reported earnings per share of $13.95.
Enterprise value:
60.4B
EV / Invested capital:
--
Price / LTM sales:
0.77x
EV / EBIT:
5.65x
EV / Revenue:
0.90x
PEG ratio (5yr expected):
0.06x
EV / Free cash flow:
6.99x
Price / Operating cash flow:
5.97x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
7.83%
Net Income Margin (TTM):
12.46%
Return On Equity:
35.98%
Return On Invested Capital:
26.63%
Operating Margin:
24.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $55.9B | $62.4B | $66.8B | $16.6B | $17.3B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$2.1B | $5.6B | $9.5B | $1.6B | $4.2B | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$7.91 | $15.49 | $30.89 | $4.33 | $13.95 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $16.8B | $16.8B | $18.3B | $22.1B | $24B | |
| Total Assets | $123B | $87.7B | $92.1B | $104.7B | $110.9B | |
| Current Liabilities | $33.4B | $38.7B | $43.3B | $46.7B | $46.4B | |
| Total Liabilities | $96.3B | $70.2B | $77.6B | $83.9B | $83.4B | |
| Total Equity | $26.7B | $17.6B | $14.4B | $20.8B | $27.5B | |
| Total Debt | $8B | $8B | $7.9B | $8.1B | $8.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4B | $8.5B | $8.8B | $3.2B | $3.3B | |
| Cash From Investing | -$2.3B | -$7.7B | -$7B | -$2.7B | -$2.8B | |
| Cash From Financing | -$1.6B | -$695M | -$1.8B | -$185M | -$634M | |
| Free Cash Flow | $3.7B | $8.2B | $8.6B | $3.1B | $3.2B | |
ALL
Sector
Market Cap
$50.3B
$537.2M
Price % of 52-Week High
89.06%
92.07%
Dividend Yield
2.08%
1.5%
Shareholder Yield
3.16%
3.06%
1-Year Price Total Return
0.62%
8.37%
Beta (5-Year)
0.243
0.451
Dividend yield:
2.08%
Annualized payout:
$3.68
Payout ratio:
7.17%
Growth streak:
14 years
Technicals
8-day SMA
Sell
Level
$202.58
200-day SMA
Sell
Level
$202.10
Bollinger Bands (100)
Sell
Level
197.86 - 211.1
Chaikin Money Flow
Buy
Level
300.8M
20-day SMA
Sell
Level
$205.69
Relative Strength Index (RSI14)
Sell
Level
30.89
ADX Line
Sell
Level
17.12
Williams %R
Buy
Level
-97.931
50-day SMA
Sell
Level
$206.63
MACD (12, 26)
Sell
Level
-2.53
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
367.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5835)
Sell
CA Score
(Annual)
Level (-1.358)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (0.3121)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Allstate Corp. engages in the property and casualty insurance business and the provision of protection solutions. It operates through the following segments: Allstate Protection, Protection Services, Allstate Health and Benefits, Run-off Property-Liability, and Corporate and Other. The Allstate Protection segment offers private passenger auto, homeowners, other personal lines, and commercial insurance marketed under the Allstate, National General, and Answer Financial brand names. The Protection Services segment provides a range of solutions and services that expand and enhance customer value propositions including Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, and Allstate Identity Protection. The Allstate Health and Benefits segment focuses on voluntary benefits and individual life and health products, including life, accident, critical illness, short term disability, and other health insurance products sold through independent agents, benefit brokers, and Allstate exclusive agencies. The Run-off Property-Liability segment relates to property and casualty insurance policies with exposure to asbestos, environmental, and other claims in run-off. The Corporate and Other segment is involved in debt service, holding company activities, and certain non-insurance operations. The company was founded on April 17, 1931 and is headquartered in Northbrook, IL.
Stock Forecast FAQ
In the current month, ALL has received 11 Buy ratings 8 Hold ratings, and 0 Sell ratings. The ALL average analyst price target in the past 3 months is $236.29.
-
Where Will The Allstate Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Allstate Corp. share price will rise to $236.29 per share over the next 12 months.
-
What Do Analysts Say About The Allstate Corp.?
Analysts are divided on their view about The Allstate Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Allstate Corp. is a Sell and believe this share price will drop from its current level to $157.00.
-
What Is The Allstate Corp.'s Price Target?
The price target for The Allstate Corp. over the next 1-year time period is forecast to be $236.29 according to 19 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is ALL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Allstate Corp. is a Buy. 11 of 19 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ALL?
You can purchase shares of The Allstate Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Allstate Corp. shares.
-
What Is The The Allstate Corp. Share Price Today?
The Allstate Corp. was last trading at $192.25 per share. This represents the most recent stock quote for The Allstate Corp.. Yesterday, The Allstate Corp. closed at $192.28 per share.
-
How To Buy The Allstate Corp. Stock Online?
In order to purchase The Allstate Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ALL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ALL
Sector
P/E ratio
6.23x
12.32x
PEG ratio
0.06x
0.31x
P/B ratio
1.97x
1.12x
Price / LTM sales
0.77x
1.83x
Growth Metrics
ALL
Sector
Revenue growth
3.78%
5.35%
Earnings growth
222.08%
14.24%
Revenue (5-year growth)
7.49%
8.79%
Earnings forecast
$6.91
$0.64
Profitability
ALL
Sector
Profitability FY 2024
--
--
Return on invested capital
26.63%
4.96%
Return on assets
7.83%
1%
Return on equity
35.98%
9.65%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
ALL
Sector
Total cash
$10.6B
$412.1M
Short term investments
$4.5B
$193.9M
Total assets
$104.8B
$3B
Long term debt
$8.1B
$75.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
